Treatment options for schizophrenia with Prof Andrea Fagiolini
Prof Andrea Fagiolini, Professor of Psychiatry from the University of Siena, shares his expert opinion on the use of REXULTI and partial agonists for the treatment of schizophrenia.
-
Body
PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia. This product is not listed on the PBS for the treatment of agitation associated with Alzheimer’s dementia.
-
Body
Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:REXULTI® is a registered trademark of H. Lundbeck A/S. REXULTI® is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
Contributor
Prof Andrea Fagiolini